Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis. Carcelén-Gadea M, Ferrer-Garcia J C, Cervelló Donderis A Neurol Sci. 2013 Aug 13. Epub 2013 Aug 13. PMID: 23942788. Abstract CommentRecommendBookmarkWatch